abrdn Life Sciences Investors (NYSE:HQL) Raises Dividend to $0.62 Per Share

abrdn Life Sciences Investors (NYSE:HQL) declared a quarterly dividend on Tuesday, August 11th. Shareholders of record on Monday, August 24th will be given a dividend of 0.62 per share on Monday, August 31st. This represents a c) annualized dividend and a yield of 11.7%. The ex-dividend date is Monday, August 24th. This is a 10.7% increase from abrdn Life Sciences Investors’s previous quarterly dividend of $0.56.

abrdn Life Sciences Investors Trading Up 0.5%

Shares of NYSE:HQL traded up $0.10 during trading on Wednesday, reaching $21.20. 41,290 shares of the stock were exchanged, compared to its average volume of 126,951. abrdn Life Sciences Investors has a 12 month low of $13.44 and a 12 month high of $21.32. The stock has a 50-day moving average price of $19.11 and a 200-day moving average price of $17.81.

About abrdn Life Sciences Investors

abrdn Life Sciences Investors (NYSE: HQL) is a closed-end management investment company that seeks capital appreciation through investment in the life sciences sector. Established in 1994, the trust focuses on equity and equity-related securities of companies engaged in biotechnology, pharmaceuticals, medical devices, diagnostics and related fields. Its closed-end structure allows portfolio managers to maintain a stable pool of capital, pursue long-term investment strategies and employ leverage when deemed appropriate.

The fund’s portfolio spans both public and private companies, with an emphasis on businesses driving innovation in drug development, gene therapy, precision medicine and healthcare technology.